SBIR-STTR Award

Autoscreen: an Innovative E-Health Solution for Early Identification of Autism Spectrum Disorder
Award last edited on: 3/3/2021

Sponsored Program
SBIR
Awarding Agency
NIH : NIMH
Total Award Amount
$1,256,616
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Joshua W Wade

Company Information

Adaptive Technology Consulting LLC (AKA: ATC)

1732 Sunray Drive
Murfreesboro, TN 37127
   (931) 205-0564
   N/A
   www.innovateatc.com
Location: Single
Congr. District: 04
County: Rutherford

Phase I

Contract Number: 1R43MH115528-01A1
Start Date: 8/23/2018    Completed: 2/22/2019
Phase I year
2018
Phase I Amount
$224,978
Early accurate identification and treatment of young children with Autism Spectrum Disorder (ASD) represents a pressing public health and clinical care challenge. Given mounting evidence that early, accurate diagnosis of ASD is possible and very young children who receive intervention can demonstrate substantial gains in functioning, current American Academy of Pediatrics practice guidelines endorse formal ASD screening at 18 and 24 months of age. Ideally, this recommended screening would translate into early diagnosis and treatment for most children. Unfortunately, large numbers of children are still not screened for ASD; waits for specialized diagnostic assessment can be very long; and the average age of diagnosis in the US remains between 4 to 5 years of age. Further, groups from traditionally underserved communities are even more likely to be diagnosed at later ages. Delays in accurate diagnosis contribute to high levels of family stress and limit access to ASD behavioral intervention services, which are increasingly recognized as very important to children?s functioning. The current project tests a novel e-health system (?Autoscreen?) for rapid screening, diagnostic triage, referral, and treatment engagement of young children within community pediatric settings, with an embedded focus on reaching underserved populations. This tool fuses advanced computational strategies with expert knowledge and tools for ASD screening/assessment in order to realize an e-health application that not only provides support for enhanced screening across diverse communities, but also establishes a clear decision pathway for early, accurate diagnostic triage and meaningful engagement in early treatment. We will integrate (a) our computational analyses of gold-standard assessments conducted across a very large-sample of toddlers with ASD and other developmental concerns with (b) a novel interactive assessment designed to target core areas of earliest ASD vulnerability, in order to create an e-screening application that can guide early action within traditional community pediatric settings. We will rigorously evaluate the feasibility, usability, compatibility, and potential utility of this tool in the current work. This evaluation will be conducted in order to ultimately create and test the efficacy of this innovative e-health product in terms of identifying and linking children with ASD more rapidly to meaningful interventions at young ages. We believe the potential market for such a system is quite substantial with common use developmental screening instruments identifying roughly 7-9% of children in first year of life. In this capacity, our tool will ultimately be designed as a practical, feasible, and reimbursable health-screening module for wide-scale use in community pediatric settings.

Project Terms:
5 year old; Academy; accurate diagnosis; Age; Age-Months; American; Area; autism spectrum disorder; base; Behavior Therapy; Blinded; care providers; care systems; Child; Childhood; Classification; Clinical; clinical care; Communities; Computer Analysis; Data; Data Set; design; Detection; Development; Diagnosis; Diagnostic; Early Diagnosis; Early identification; Early treatment; efficacy testing; eHealth; Eligibility Determination; Evaluation; Family; formative assessment; Gold; Health; health application; Health system; Healthcare; innovation; instrument; Intervention; Knowledge; learning strategy; Life; Link; Machine Learning; Mainstreaming; Modeling; multidisciplinary; novel; Paper; Parents; Pathway interactions; Pediatrics; Phase; Practice Guidelines; Primary Health Care; Process; Protocols documentation; prototype; Provider; psychologic; Psychometrics; Public Health; rapid diagnosis; recruit; Research; Resources; Risk; Sample Size; Sampling; satisfaction; screening; service intervention; Services; statistics; Stress; System; telehealth; Testing; Toddler; tool; Translating; Triage; Underserved Population; uptake; usability; Work;

Phase II

Contract Number: 2R44MH115528-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2019
(last award dollars: 2020)
Phase II Amount
$1,031,638

Early accurate identification and treatment of young children with Autism Spectrum Disorder (ASD) represents a pressing public health and clinical care challenge. Given mounting evidence that early, accurate diagnosis of ASD is possible and that very young children who receive intervention can demonstrate substantial gains in functioning, current American Academy of Pediatrics practice guidelines endorse formal ASD screening at 18 and 24 months of age. Ideally, this recommended screening would translate into early diagnosis and treatment for most children. Unfortunately, large numbers of children are still not screened for ASD; waits for specialized diagnostic assessment can be very long; and the average age of diagnosis in the US remains between 4 to 5 years of age. Furthermore, groups from traditionally underserved communities are even more likely to be diagnosed at later ages. Delays in accurate diagnosis contribute to high levels of family stress and limit access to ASD behavioral intervention services, which are increasingly recognized as very important to children’s functioning. Continuing work initiated in our Phase I project, the current project rigorously tests “Autoscreen”—a digital tool for rapid screening, diagnostic triage, referral, and treatment engagement of young children within community pediatric settings, with an embedded focus on reaching underserved populations. This tool fuses advanced computational strategies with expert knowledge and tools for ASD screening/assessment in order to realize a commercial tool that not only provides support for enhanced, reimbursable screening across diverse communities, but also establishes a clear decision pathway for early, accurate diagnostic triage and meaningful engagement in early treatment. In Phase II, we will rigorously evaluate the validity and broader clinical utility of Autoscreen. If successful, this innovative product could identify and link children with ASD to meaningful interventions at younger ages. We believe that a substantial potential market for such a system exists, given that commonly used developmental screening instruments identify roughly 8% of children as showing developmental risks in first years of life. In this capacity, our tool will ultimately be designed as a practical, feasible, and reimbursable health-screening module for wide-scale use in community pediatric settings.

Public Health Relevance Statement:
PROJECT NARRATIVE Early accurate identification and treatment of young children with Autism Spectrum Disorder (ASD) represents a pressing public health and clinical care challenge. Continuing our Phase I work, the current project rigorously tests “Autoscreen”—a digital tool for rapid screening, diagnostic triage, referral, and treatment engagement of young children with ASD concerns within community pediatric settings. Autoscreen fuses advanced computational strategies with expert knowledge and tools for ASD screening. It offers community providers an accessible, commercially viable digital platform for enhanced, reimbursable screening across settings. It then gives providers decision pathways for early, accurate diagnostic triage, which could speed treatment initiation and improve outcomes.

Project Terms:
5 year old; Academy; accurate diagnosis; Address; Age; Age-Months; Agreement; Ambulatory Care; American; Area; autism spectrum disorder; autistic children; base; Behavior; Behavior Therapy; Behavioral; Benchmarking; Caregivers; Child; Child Behavior; Childhood; Classification; Clinical; clinical care; clinical Diagnosis; Code; communication behavior; Communities; Complex; cost; Data; design; Development; Diagnosis; Diagnostic; digital; Dimensions; disorder risk; Early Diagnosis; Early identification; Early Intervention; early screening; Early treatment; Effectiveness; eHealth; Electronic Health Record; Enhancement Technology; Evaluation; Family; Feedback; Guidelines; Health; Healthcare; Impairment; improved; improved outcome; indexing; Individual; innovation; Instruction; instrument; interest; Intervention; Interview; Knowledge; Life; Link; Longevity; Measures; Medical; medical specialties; Neurodevelopmental Disorder; Outcome; Parents; Pathway interactions; Pattern; pediatrician; Pediatrics; Performance; Phase; Positioning Attribute; Practice Guidelines; predictive modeling; Predictive Value; Prevalence; prototype; Provider; Public Health; Questionnaires; Receiver Operating Characteristics; Reporting; Research; Resources; Risk; screening; screening guidelines; Sensitivity and Specificity; service intervention; social communication; Social isolation; Specificity; Speed; Stress; Structure; success; Symptoms; System; technological innovation; Technology; Testing; tool; Translating; Triage; Underserved Population; Unemployment; United States; usability; Visit; Wait Time; Work